Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.-Reference-Cited by-同舟云学术

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

Published:1997-01-01 Issue:1 Volume:99 Page:62-66
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Garin M C,James R W,Dussoix P,Blanché H,Passa P,Froguel P,Ruiz J

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Cited by 424 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case–Control Study Supports Genetic Contribution of the PON Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease;Antioxidants;2024-08-29

2. Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis;Antioxidants;2023-11-23

3. CDKN2B‐AS (rs2891168), SOD2 (rs4880), and PON1 (rs662) polymorphisms and susceptibility to coronary artery disease and type 2 diabetes mellitus in Iranian patients: A case‐control study;Health Science Reports;2023-11

4. 5‐(3′,4′‐Dihydroxyphenyl)‐γ‐Valerolactone Is a Substrate for Human Paraoxonase: A Novel Pathway in Flavan‐3‐ol Metabolism;Molecular Nutrition & Food Research;2023-07-09

5. Effect of Exercise Repetitions on Arylesterase Activity of PON1 in Plasma of Average-Trained Men—The Dissociation between Activity and Concentration;Antioxidants;2023-06-17